|
FBRX
|
Forte Biosciences, Inc.
|
US
|
NASDAQ
|
|
FSTX
|
F-star Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
US
|
NASDAQ
|
|
HOTH
|
Hoth Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IDNA
|
iShares Genomics Immunology and Healthcare ETF
|
US
|
AMEX
|
|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
US
|
NASDAQ
|
|
IMNM
|
Immunome, Inc.
|
US
|
NASDAQ
|
|
IMUX
|
Immunic, Inc.
|
US
|
NASDAQ
|
|
INKT
|
MiNK Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IPA
|
ImmunoPrecise Antibodies Ltd.
|
US
|
NASDAQ
|
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
|
IVVD
|
Invivyd, Inc.
|
US
|
NASDAQ
|
|
JANX
|
Janux Therapeutics, Inc.
|
US
|
NASDAQ
|
|
JNCE
|
Jounce Therapeutics, Inc.
|
US
|
NASDAQ
|
|
JNJ
|
Johnson & Johnson
|
US
|
NYSE
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MDNA
|
Medicenna Therapeutics Corp.
|
US
|
NASDAQ
|